Stay updated on Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page.

Latest updates to the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now shows Revision: v3.4.2 and the prior government-funding status notice (v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check22 days agoChange DetectedA site-wide funding notice regarding government funding and operations was added, and the site revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check30 days agoChange DetectedAdded a 'Show glossary' option. Updated metadata labels, including 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and updated the revision to 'Revision: v3.4.0' (from 'Revision: v3.3.4').SummaryDifference0.2%

- Check44 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 with no changes to study details, eligibility criteria, or enrollment information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded a Texas listing under a new Locations section and removed the old 'Texas Locations' label to clarify site listings.SummaryDifference0.2%

- Check93 days agoChange DetectedThe page shows a minor site revision update: the addition of 'Revision: v3.3.2' and the removal of the previous 'Revision: v3.2.0', which does not affect study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page.